A novel test developed by Duke-NUS researchers enables real-time monitoring of T cells that have been engineered to fight cancer after re-introduction into the body of a cancer patient. This simple and innovative test provides clinicians with the ability to track the function of these cancer-fighting cells over the course of the treatment.
This article was originally published on MedicalXpress.com